Group 1 - The core viewpoint of the article highlights the active investment landscape in China's primary market, with a total of 124 financing events reported this week, an increase of 53 events compared to the previous week, and a total financing scale of 10.096 billion RMB [7] - The most active sectors in terms of financing events are artificial intelligence, intelligent manufacturing, and healthcare, with 29, 23, and 13 events respectively [9] - The total disclosed financing amount in the intelligent manufacturing sector reached approximately 3.651 billion RMB, with notable investments such as LimX Dynamics securing 200 million USD in Series A funding [9][10] Group 2 - The geographical distribution of disclosed investment events shows a concentration in Jiangsu, Guangdong, and Shanghai, with Jiangsu reporting 27 events, Guangdong 25 events, and Shanghai 16 events [13] - The stage distribution of the disclosed investment events indicates that 101 are early-stage, 18 are growth-stage, and 5 are late-stage [17] - This week, 13 completed M&A events were reported, with an increase of 4 events compared to the previous week, primarily in the intelligent manufacturing, enterprise services, and energy sectors [49]

Summary of Key Points Core Viewpoint - The A-share IPO market is active with three companies approved for listing, while the Hong Kong IPO market continues to thrive, particularly in the innovative drug and high-end manufacturing sectors, with several key players making significant moves [2][6]. Group 1: A-share IPO Approvals - Three companies received approval for IPOs this week: Guangdong Huahui Intelligent Equipment Co., Ltd., Anhui Xinfeng New Energy Technology Co., Ltd., and Shandong Chunguang Technology Group Co., Ltd. [2][3][4]. - Huahui Intelligent focuses on high-end intelligent equipment and has seen rapid revenue growth, projecting over 4.2 billion yuan in revenue for 2024 and over 620 million yuan in net profit [3]. - Xinfeng Technology specializes in thermal management components for electric vehicles, with projected revenues of 6 billion yuan in 2024 and 13.81 billion yuan in 2025 [4][5]. - Chunguang Group leads in the production of soft magnetic ferrite powder, with revenues of 10.15 billion yuan in 2022 and a planned fundraising of 7.51 billion yuan for its IPO [5]. Group 2: Hong Kong IPO Market Activity - The Hong Kong IPO market welcomed five new listings, including four companies and one on the Sci-Tech Innovation Board, covering diverse sectors such as chemical new materials and cardiovascular medical devices [6][7]. - Guoen Technology debuted on the Hong Kong Stock Exchange, raising approximately 1 billion HKD, with plans for expansion in Thailand and domestic production [6]. - Beixin Life, the first medical device company listed on the Sci-Tech Innovation Board, saw its stock price surge by 183.33% on its first day, focusing on cardiovascular intervention devices [7]. - Leading companies in the PCB equipment sector, such as Dazhu CNC, raised significant funds for expansion into Southeast Asia, while Zhuozheng Medical and Muyuan Foods had mixed performances post-listing [8]. Group 3: Upcoming IPOs and Market Trends - The Hong Kong IPO market continues to be driven by hard technology, with companies like Danuo Pharmaceutical and Xian Dao Intelligent preparing for their listings, focusing on innovative drugs and lithium battery equipment [9][10]. - Danuo Pharmaceutical is set to raise funds for global clinical advancements, with its core product showing promising clinical data [9]. - Xian Dao Intelligent aims to raise 41.66 billion HKD, with a significant projected profit increase of 424% by 2025, expanding its services beyond lithium battery equipment [10]. - Wolong Nuclear Materials is also preparing for an IPO, focusing on new materials and global capacity expansion, with a fundraising target of up to 27.34 billion HKD [11].

Group 1 - The core viewpoint of the articles highlights the successful listing of Muyuan Foods Co., Ltd. on the Hong Kong Stock Exchange, marking it as the first dual-listed pig farming company in China, which enhances its international financing channels and corporate governance [1][2] - The global offering of H-shares amounted to 274 million shares, with both the Hong Kong public offering and international placement being oversubscribed, attracting cornerstone investments from notable institutions totaling HKD 53.42 billion [1] - On its first trading day, the stock closed at HKD 40.52 per share, reflecting a 3.9% increase, raising approximately HKD 11.1 billion and achieving a total market capitalization of HKD 232.5 billion [1] Group 2 - Approximately 60% of the raised funds will be allocated for overseas business expansion in Southeast Asia, while 30% will be invested in core technology development such as breeding and smart farming [2] - Muyuan Foods aims to sell 77.981 million pigs by 2025, with the complete cost of pig farming expected to decrease to CNY 11.3 per kilogram, showcasing its cost-reduction capabilities and robust asset structure, which have gained high recognition from international capital [2]

目前，公司已按期完成了上述债券的兑付工作，共支付本息合计人民币304,327,397.26元。 格隆汇2月6日丨牧原股份(02714.HK)公告，牧原食品股份有限公司于2025年5月9日发行了2025年度第一 期科技创新债券(简称：25牧原食品SCP001(科创债)，代码：012581123)，发行总额为人民币3亿元，发 行利率1.95%，起息日为2025年5月12日，兑付日为2026年2月6日。具体内容详见2025年5月13日披露于 《证券时报》《中国证券报》《上海证券报》《证券日报》及巨潮资讯网(www.cninfo.com.cn)的《牧原 食品股份有限公司关于2025年度第一期科技创新债券发行结果的公告》(公告编号：2025-048)。 ...

智通财经APP讯，牧原股份(02714)发布公告，公司于2025年5月9日发行了2025年度第一期科技创新债券 (简称：25牧原食品SCP001(科创债)，代码：012581123)，发行总额为人民币3亿元，发行利率1.95%， 起息日为2025年5月12日，兑付日为2026年2月6日。目前，公司已按期完成了上述债券的兑付工作，共 支付本息合计人民币3.04亿元。 ...

格隆汇2月6日丨牧原股份(02714.HK)公告，牧原食品股份有限公司于2025年5月9日发行了2025年度第一 期科技创新债券(简称：25牧原食品SCP001(科创债)，代码：012581123)，发行总额为人民币3亿元，发 行利率1.95%，起息日为2025年5月12日，兑付日为2026年2月6日。具体内容详见2025年5月13日披露于 《证券时报》《中国证券报》《上海证券报》《证券日报》及巨潮资讯网(www.cninfo.com.cn)的《牧原 食品股份有限公司关于2025年度第一期科技创新债券发行结果的公告》(公告编号：2025-048)。 目前，公司已按期完成了上述债券的兑付工作，共支付本息合计人民币304,327,397.26元。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容所產生或因依賴 該等內容而引致的任何損失承擔任何責任。 MUYUAN FOODS CO., LTD. 牧原食品股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 中國，河南省南陽市，2026年2月6日 海外監管公告 本公告乃由根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 茲載列本公司於深圳證券交易所網站刊登的《牧原食品股份有限公司關於2025年 度第一期科技創新債券兌付完成的公告》，僅供參閱。 承董事會命 牧原食品股份有限公司 董事長兼總裁 秦英林先生 於本公告日期，董事會成員包括：(i)執行董事秦英林先生、曹治年先生及楊瑞 華女士；(ii)非執行董事錢瑛女士及蘇黨林先生；及(iii)獨立非執行董事周明笙先 生、閻磊先生及馮根福先生。 | 证券代码：002714 | 证券简称：牧原股份 | 公告编号：2026-017 | | --- | --- | --- | | 债券代码：127045 | 债券简称：牧原转债 | | （股份代號：27 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容所產生或因依賴 該等內容而引致的任何損失承擔任何責任。 海外監管公告 本公告乃由根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 茲載列本公司於深圳證券交易所網站刊登的《牧原食品股份有限公司關於控股股 東及一致行動人權益變動觸及1%和5%整數倍的提示性公告》，僅供參閱。 承董事會命 牧原食品股份有限公司 董事長兼總裁 秦英林先生 中國，河南省南陽市，2026年2月6日 MUYUAN FOODS CO., LTD. 牧原食品股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2714） 提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 本次权益变动属于牧原食品股份有限公司（以下简称"公司"）发行境外上 市股份（H 股）股票并在香港联合交易所有限公司主板挂牌上市引起公司总股本 增加，进而导致公司控股股东及其一致行动人持股比例被动稀释，不触及要约收 购。 本次权益 ...

中国经济网北京2月6日讯 牧原食品股份有限公司（以下简称"牧原股份"，02714.HK）今日在港交所上市，截至收盘 报40.52港元，涨幅3.9%。 配发结果公告显示，牧原股份全球发售的发售股份数目为273,951,400股H股（视乎超额配股权使与否而定），其 中，香港发售股份数目为27,395,200股H股，国际发售股份数目为246,556,200股H股（视乎超额配股权行使与否而定）。 | 發售股份及股本 | | | --- | --- | | 發售股份數目(於超額配股權獲行使前) | 273.951,400 | | 香港公開發售的發售股份數目 | 27,395,200 | | 國際發售的發售股份數目(於超額配股權獲行使前) | 246,556,200 | | 於上市時已發行的股份數目(於超額配股權獲行使前)(1) 5.736.722.666 | | | | 價格資料 | | --- | --- | | 最終發售價 | 39.00港元 | | 最高發售價 | 39.00港元 | | 所得款項 | | | --- | --- | | 所得款項總額 | 10.684.1 百萬港元 | | 減：按最終發售價計算的 ...

2月6日，牧原股份正式在香港联合交易所主板上市，证券简称为"牧原股份"，股份代码02714.HK，成为国内首家实现A+H双上市的生猪养殖企业。 牧原股份董事长秦英林在上市仪式致辞中表示："港股上市，开启国际化进程。我们将借力国际平台，坚持创新，做好主业，助力猪肉产业发展成为现代 先进产业，让养猪更轻松，猪肉更美味，为人民美好生活，贡献牧原力量！" 截至午间休市，牧原股份港股上涨4.72%，报40.84港元/股，市值超2300亿港元。 | < V | 牧原股份 | | CG Q | | --- | --- | --- | --- | | | 02714 | | | | | 39.000 最高 40.840 27 | 40.980 最低 38.980 | | | | 9.33% 总手 472% 1840 快手 | 2556万 金额 | 10.15亿 | | | 总值 2343亿 市盈TTM 9.81 市净 | 2.82 | 申示 | | | 牧原转债 136.501 +0.48% | 转股溢价率 28.05% > | | | 分时 | 周Ｋ 月Ｋ 五日 | | 更多, ◎ | | 40.980 | | 5.08% ...